{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:20:09Z","timestamp":1784679609473,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ygyno.2024.01.031","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T06:30:26Z","timestamp":1706769026000},"page":"103-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Critical decisions: A mixed-methods study of decision-making among diverse gynecologic cancer patients considering therapeutic clinical trial enrollment"],"prefix":"10.1016","volume":"184","author":[{"given":"Stephanie Margrit","family":"Rieder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Rutledge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Sussman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawny","family":"Boyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vernon Shane","family":"Pankratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miria","family":"Kano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2024.01.031_bb0005","series-title":"Increasing Minority Enrollment Onto Clinical Trials: Practical Strategies and Challenges Emerge From the NRG Oncology Accrual Workshop","author":"Brooks","year":"2015"},{"key":"10.1016\/j.ygyno.2024.01.031_bb0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1200\/EDBK_156686","article-title":"Role of clinical trial participation in cancer research: barriers, evidence, and strategies","volume":"35","author":"Unger","year":"2016","journal-title":"Am. Soc. Clin. Oncol. Educ. Book Am. Soc. Clin. Oncol. Meet."},{"issue":"2","key":"10.1016\/j.ygyno.2024.01.031_bb0015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ygyno.2015.05.014","article-title":"Minority participation in gynecologic oncology group (GOG) studies","volume":"138","author":"Scalici","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2024.01.031_bb0020","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/107327481602300404","article-title":"Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer","volume":"23","author":"Hamel","year":"2016","journal-title":"Cancer Control"},{"key":"10.1016\/j.ygyno.2024.01.031_bb0025","series-title":"Barriers to Participation in Therapeutic Clinical Trials as Perceived by Community Oncologists","author":"Wong","year":"2023"},{"issue":"3","key":"10.1016\/j.ygyno.2024.01.031_bb0030","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1548-1387.2012.01222.x","article-title":"Recruitment practices and the politics of inclusion in Cancer clinical trials","volume":"26","author":"Joseph","year":"2012","journal-title":"Med. Anthropol. Q."},{"issue":"1","key":"10.1016\/j.ygyno.2024.01.031_bb0035","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/0272989X13497264","article-title":"Participation in cancer clinical trials: why are patients not participating?","volume":"34","author":"Byrne","year":"2014","journal-title":"Med. Decis. Mak."},{"key":"10.1016\/j.ygyno.2024.01.031_bb0040","series-title":"Engaging limited English proficient and ethnically diverse low-income women in health research: a randomized trial of a patient navigator intervention","author":"Nickell","year":"2019"},{"issue":"8","key":"10.1016\/j.ygyno.2024.01.031_bb0045","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1634\/theoncologist.2019-0146","article-title":"Addressing the financial burden of cancer clinical trial participation: longitudinal effects of an equity intervention","volume":"24","author":"Nipp","year":"2019","journal-title":"Oncologist."},{"issue":"22","key":"10.1016\/j.ygyno.2024.01.031_bb0050","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1002\/cncr.34455","article-title":"Associations between geography, decision-making style, and interest in cancer clinical trial participation","volume":"128","author":"Caston","year":"2022","journal-title":"Cancer."},{"issue":"5","key":"10.1016\/j.ygyno.2024.01.031_bb0055","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/jncics\/pkaa060","article-title":"Racial and ethnic disparities among participants in US-based phase 3 randomized cancer clinical trials","volume":"4","author":"Grant","year":"2020","journal-title":"JNCI Cancer Spectr."},{"key":"10.1016\/j.ygyno.2024.01.031_bb0060","series-title":"Care Ethics in the Age of Precarity","first-page":"91","article-title":"Precariousness, precarity, precariat, precarization, and social redundancy","author":"Baart","year":"2021"},{"issue":"1","key":"10.1016\/j.ygyno.2024.01.031_bb0065","first-page":"1450","article-title":"From prospective clinical trial to reducing social inequalities in health: the DESSEIN trial, concept and design of a multidisciplinary study in precarious patients with breast cancer","volume":"19","author":"Ng\u00f4","year":"2019","journal-title":"Public Health"},{"key":"10.1016\/j.ygyno.2024.01.031_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2019.112683","article-title":"Precarity and health: theorizing the intersection of multiple material-need insecurities, stigma, and illness among women in the United States","volume":"245","author":"Whittle","year":"2020","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.ygyno.2024.01.031_bb0075","series-title":"Frames of War. Verso","author":"Butler","year":"2010"},{"issue":"1","key":"10.1016\/j.ygyno.2024.01.031_bb0080","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11606-013-2568-0","article-title":"Psychometric properties of the brief health literacy screen in clinical practice","volume":"29","author":"Wallston","year":"2014","journal-title":"J. Gen. Intern. Med."},{"issue":"8","key":"10.1016\/j.ygyno.2024.01.031_bb0085","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1177\/0272989X15581800","article-title":"Validation of a short, 3-item version of the subjective numeracy scale","volume":"35","author":"McNaughton","year":"2015","journal-title":"Med. Decis. Mak."},{"issue":"5","key":"10.1016\/j.ygyno.2024.01.031_bb0090","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jpainsymman.2013.06.010","article-title":"Decisional control preferences, disclosure of information preferences, and satisfaction among hispanic patients with advanced cancer","volume":"47","author":"Noguera","year":"2014","journal-title":"J. Pain Symptom Manag."},{"issue":"7","key":"10.1016\/j.ygyno.2024.01.031_bb0095","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.pec.2017.02.011","article-title":"Psychometric evaluation and design of patient-centered communication measures for cancer care settings","volume":"100","author":"Reeve","year":"2017","journal-title":"Patient Educ. Couns."},{"issue":"1","key":"10.1016\/j.ygyno.2024.01.031_bb0100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pec.2009.09.034","article-title":"The 9-item Shared Decision Making Questionnaire (SDM-Q-9). Development and psychometric properties in a primary care sample","volume":"80","author":"Kriston","year":"2010","journal-title":"Patient Educ. Couns."},{"issue":"1","key":"10.1016\/j.ygyno.2024.01.031_bb0105","first-page":"25","article-title":"Validation of a decisional conflict scale","volume":"15","author":"O\u2019connor","year":"1995"},{"issue":"11","key":"10.1016\/j.ygyno.2024.01.031_bb0110","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1007\/s12094-017-1671-9","article-title":"Validation of SDM-Q-Doc Questionnaire to measure shared decision-making physician\u2019s perspective in oncology practice","volume":"19","author":"Calderon","year":"2017","journal-title":"Clin. Transl. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2024.01.031_bb0115","doi-asserted-by":"crossref","first-page":"E34","DOI":"10.1097\/NCC.0000000000000607","article-title":"Rasch analysis of the 9-item shared decision making questionnaire in women with breast cancer","volume":"42","author":"Wu","year":"2019","journal-title":"Cancer Nurs."},{"issue":"1","key":"10.1016\/j.ygyno.2024.01.031_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-017-3804-5","article-title":"Partnering around cancer clinical trials (PACCT): study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials","volume":"17","author":"Eggly","year":"2017","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2024.01.031_bb0125","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/pon.4226","article-title":"Attitudes toward family involvement in cancer treatment decision making: the perspectives of patients, family caregivers, and their oncologists","volume":"26","author":"Shin","year":"2017","journal-title":"Psychooncology."},{"issue":"2","key":"10.1016\/j.ygyno.2024.01.031_bb0130","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.pec.2012.03.005","article-title":"Development and psychometric properties of the shared decision making questionnaire - physician version (SDM-Q-Doc)","volume":"88","author":"Scholl","year":"2012","journal-title":"Patient Educ. Couns."},{"issue":"1","key":"10.1016\/j.ygyno.2024.01.031_bb0135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/0272989X9901900105","article-title":"A method for evaluating health care providers\u2019 decision making: the provider decision process assessment instrument","volume":"19","author":"Dolan","year":"1999","journal-title":"Med. Decis. Mak."},{"issue":"1","key":"10.1016\/j.ygyno.2024.01.031_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-018-5071-5","article-title":"Decisional conflict of physicians during the decision-making process for a simulated advanced-stage cancer patient: an international longitudinal study with German and Belgian physicians","volume":"18","author":"Schoenfeld","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2024.01.031_bb0145","series-title":"Constructing Grounded Theory","author":"Charmaz","year":"2014"},{"issue":"3","key":"10.1016\/j.ygyno.2024.01.031_bb0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0735275112457914","article-title":"Theory construction in qualitative research","volume":"30","author":"Timmermans","year":"2012","journal-title":"Soc. Theory"},{"key":"10.1016\/j.ygyno.2024.01.031_bb0155","series-title":"Advances in Mixed Methods Research","article-title":"7 quality of inferences in mixed methods research: Calling for an integrative framework","author":"Bergman","year":"2008"},{"key":"10.1016\/j.ygyno.2024.01.031_bb0160","unstructured":"United States Department of Agriculture ERS. Rural-Urban Commuting Area Codes. Accessed December 11, 2023. https:\/\/www.ers.usda.gov\/data-products\/rural-urban-commuting-area-codes\/"},{"key":"10.1016\/j.ygyno.2024.01.031_bb0165","doi-asserted-by":"crossref","unstructured":"Chen MS, Lara PN, Dang JHT, Paterniti DA, Kelly K. Twenty Years Post-NIH Revitalization Act: Renewing the Case for Enhancing Minority Participation in Cancer Clinical Trials. https:\/\/doi.org\/10.1002\/cncr.28575.","DOI":"10.1002\/cncr.28575"},{"issue":"3","key":"10.1016\/j.ygyno.2024.01.031_bb0170","article-title":"Increasing racial and ethnic diversity in cancer clinical trials: an American society of clinical oncology and association of community cancer centers joint research statement","volume":"111","author":"Oyer","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"42","key":"10.1016\/j.ygyno.2024.01.031_bb0175","first-page":"1","article-title":"Strategies to advance equity in cancer clinical trials","volume":"42","author":"Guerra","year":"2022","journal-title":"Am. Soc. Clin. Oncol. Educ. Book Am. Soc. Clin. Oncol. Annu. Meet."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824000465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824000465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:52:26Z","timestamp":1726246346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825824000465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":35,"alternative-id":["S0090825824000465"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.01.031","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Critical decisions: A mixed-methods study of decision-making among diverse gynecologic cancer patients considering therapeutic clinical trial enrollment","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.01.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}